SCNI vs SNDL · P/E 0.2, rev $1.3M vs $357.7M cap
Scinai Immunotherapeutics Ltd (SCNI) versus SNDL Inc. (SNDL) — a side-by-side from cached financials, not a winner call.
Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
SNDL Inc. (SNDL) is a beverages - wineries & distilleries company listed on US.
Latest reported SCNI revenue for 2025-12-31 was $1.3M. Net income was -$8.3M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
SNDL does not have a complete income-statement cache yet.
SCNI currently screens at market cap $1.8M and trailing P/E 0.2. SNDL currently screens at market cap $357.7M.
Not investment advice. Open the SCNI and SNDL stock pages for the full models.
Not investment advice.